Back to resultsA Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) (LIMMITLESS)
Primary Purpose
Psoriasis
Status
Active
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
risankizumab
Sponsored by
About this trial
This is an interventional treatment trial for Psoriasis focused on measuring ABBV-066, BI 655066
Eligibility Criteria
Inclusion Criteria:
- Participants with a history of moderate to severe chronic plaque psoriasis, who have completed one of the preceding studies.
- Participants must be candidates for prolonged open label risankizumab treatment according to investigator judgment.
- Females of childbearing potential must have a negative urine pregnancy test result at Baseline.
If female, participant must be either postmenopausal, OR permanently surgically sterile OR for women of childbearing potential practicing at least one protocol specified method of birth control, starting at Baseline through at least 20 weeks after the last dose of study drug.
- Participants must have signed and dated a written informed consent in accordance with Good Clinical Practice (GCP) and local legislation prior to admission into the study.
Exclusion Criteria:
- Premature discontinuation for any reason in the preceding study.
- Participants who have developed guttate, erythrodermic, pustular or drug-induced psoriasis as diagnosed by the investigator during the preceding study.
- Use of any prohibited medication or any drug considered likely to interfere with the safe conduct of the study, as assessed by the investigator.
- Evidence of a current or previous disease, medical condition (including chronic alcohol or drug abuse) other than psoriasis, surgical procedure (i.e., organ transplant), medical examination finding (including vital signs and ECG), or laboratory value outside the reference range that in the opinion of the investigator is clinically significant and would make the study participant unreliable to adhere to the protocol or to complete the study, compromise the safety of the subject, or compromise the quality of the data.
- Previous enrollment in this study.
- Female subject who is pregnant, breastfeeding or is considering becoming pregnant during the study or within 20 weeks after the last dose of study drug.
- Time elapsed is > 8 weeks since the completion visit in the preceding study.
- Participant is considered by the investigator for any reason, to be an unsuitable candidate for the study and not able to comply with the study protocol.
Sites / Locations
- Total Skin and Beauty Derm Ctr /ID# 154000
- University of Alabama at Birmingham - Main /ID# 153983
- NW Arkansas Clinical Trials Center /ID# 154014
- Bakersfield Derma & Skin Cance /ID# 154008
- California Dermatology and Research Institute /ID# 154007
- T. Joseph Raoof, MD, Inc. /ID# 154078
- Center for Dermatology Clinical Research /ID# 154009
- Kaiser Permanente Los Angeles /ID# 154079
- Dermatology Research Associates /ID# 153977
- Wallace Medical Group /ID# 154025
- Dermatology Specialists, Inc /ID# 153984
- Huntington Medical Foundation /ID# 154002
- Medderm Associates /ID# 154098
- Southern California Dermatology /ID# 154006
- UNISON Center for Clinical Tri /ID# 153979
- New England Research Associates, LLC /ID# 154004
- UConn Health /ID# 154128
- Florida Academic Centers Research /ID# 154045
- Leavitt Medical Associates of Florida /ID# 154046
- Progressive Medical Research /ID# 154027
- Hamilton Research, LLC /ID# 153980
- Advanced Medical Research, PC /ID# 153999
- Northwestern University Feinberg School of Medicine /ID# 153974
- Rush University Medical Center /ID# 154099
- Arlington Dermatology /ID# 153975
- Northshore University Health System Dermatology Clinical Trials Unit /ID# 154011
- Dundee Dermatology /ID# 154110
- Dawes Fretzin, LLC /ID# 154146
- The Dermatology Center PSC - New Albany /ID# 154075
- The Indiana Clinical Trials Center /ID# 153976
- The South Bend Clinic Center /ID# 154147
- Epiphany Dermatology of Kansas LLC /ID# 153993
- Skin Sciences, PLLC /ID# 153991
- DS Research /ID# 154028
- Massachusetts General Hospital /ID# 153990
- ActivMed Practices and Research, LLC. /ID# 154044
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 154111
- Great Lakes Research Group, Inc. /ID# 153998
- Michigan Center for Skin Care Research /ID# 153986
- Somerset Skin Centre /ID# 154097
- Minnesota Clinical Study Center /ID# 154015
- Central Dermatology, PC /ID# 154013
- Skin Specialists, PC /ID# 154024
- Dartmouth-Hitchcock Medical Center /ID# 154095
- Psoriasis Treatment Center of Central New Jersey /ID# 154001
- Schweiger Dermatology Group /ID# 202489
- Forest Hills Dermatology Group /ID# 154113
- Icahn School of Medicine at Mount Sinai /ID# 154129
- The Rockefeller University /ID# 153994
- DermResearchCenter of New York, Inc. /ID# 154012
- Buffalo Medical Group /ID# 154148
- Darst Dermatology /ID# 154076
- Dermatology Consulting Service /ID# 154010
- Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 202490
- Wilmington Dermatology Center /ID# 154109
- Synexus Research Cincinnati /ID# 153997
- Oregon Dermatology and Research Center /ID# 153982
- Oregon Medical Res Center PC /ID# 154003
- Altoona Ctr Clinical Res /ID# 153981
- Paddington Testing Co., Inc. /ID# 154022
- University of Pittsburgh MC /ID# 153995
- Clinical Partners, LLC /ID# 154096
- Coastal Clinical Research Center of the Carolinas /ID# 154112
- Synexus Clinical Research US, Inc. /ID# 154127
- Coastal Carolina Research Center /ID# 153992
- Health Concepts /ID# 153996
- Austin Dermatology Associates /ID# 154042
- Bellaire Dermatology Associates /ID# 153987
- Modern Research Associates, PLLC /ID# 154043
- Menter Dermatology Res Inst /ID# 153985
- Center for Clinical Studies - Houston (Binz) /ID# 154005
- Suzanne Bruce and Associates-Houston /ID# 154026
- Derm Clin Res Ctr San Antonio /ID# 153978
- Progressive Clinical Research /ID# 154149
- Dermatology San Antonio /ID# 154077
- Center for Clinical Studies - Webster TX /ID# 154150
- Virginia Clinical Research, Inc. /ID# 154016
- Dermatology Associates of Seattle /ID# 153988
- Premier Clinical Research /ID# 154284
- Paratus Clinical Research Woden /ID# 154307
- St George Dermatology & Skin Cancer Centre /ID# 154308
- Specialist Connect Pty Ltd /ID# 154311
- North Eastern Health Specialists /ID# 154309
- Skin Health Institute Inc /ID# 154305
- Sinclair Dermatology /ID# 154310
- Fremantle Dermatology /ID# 154306
- Landeskrankenhaus Feldkirch /ID# 154303
- Klinik Landstrasse /ID# 154300
- Medizinische Universitaet Wien /ID# 154302
- Cliniques Universitaires de Bruxelles Hopital Erasme /ID# 154293
- UZ Brussel /ID# 154295
- UCL Saint-Luc /ID# 154294
- CHU de Liege Sart Tilman /ID# 154297
- UZ Gent /ID# 154296
- IMTR - Grand Hopital de Charleroi /ID# 154298
- Kirk Barber Research, CA /ID# 153840
- Dermatology Research Institute Inc. /ID# 153850
- Stratica Medical /ID# 153848
- Dr. Chih-ho Hong Medical Inc. /ID# 153842
- Enverus Medical Research /ID# 153851
- Karma Clinical Trials /ID# 153876
- Eastern Canada Cutaneous Resea /ID# 153870
- CCA Medical Research /ID# 153859
- Kingsway Clinical Research /ID# 154292
- Dermatrials Research /ID# 153847
- The Guenther Dermatology Research Centre /ID# 153841
- Lynderm Research Inc. /ID# 153861
- DermEdge Research Inc. /ID# 153843
- North Bay Dermatology Centre /ID# 153845
- The Centre for Clinical Trials /ID# 153871
- Dermatology Ottawa Research Centre /ID# 153862
- SKIN Centre for Dermatology /ID# 153853
- The Center For Dermatology /ID# 153844
- York Dermatology Clinic and Research Centre /ID# 153860
- Toronto Research Centre /ID# 153852
- Research Toronto /ID# 153854
- K. Papp Clinical Research /ID# 153855
- XLR8 Medical Research /ID# 153858
- Windsor Clinical Research, Inc /ID# 153877
- Innovaderm Research Inc. /ID# 153846
- Centre de Recherche dermatologique du Quebec Metropolitain /ID# 153856
- DERMAMEDICA, s.r.o. /ID# 153890
- Medical research s.r.o. /ID# 153898
- CLINTRIAL s.r.o. /ID# 153889
- CCR Czech a.s /ID# 153887
- MUDr. Blanka Havlickova - dermatovenerologie /ID# 153888
- CCR Prague s.r.o. /ID# 153897
- Terveystalo Tampere /ID# 154118
- Mehilainen Turku /ID# 154120
- Chu de Nice-Hopital L'Archet Ii /Id# 153948
- Hôpital Charles-Nicolle /ID# 205842
- CHU Toulouse - Hopital Larrey /ID# 153951
- Universitaetsklinik Heidelberg /ID# 153910
- Universitaetsklinikum Tuebingen /ID# 153912
- Universitaetsklinikum Erlangen /ID# 154093
- Universitaetsklinikum Frankfurt /ID# 153891
- Universitaetsklinikum Muenster /ID# 153895
- CMS3 Company for Medical Study /ID# 201318
- Universitaetsklinikum Leipzig /ID# 153909
- Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 153916
- DermaKiel Allergie und Haut Centrum /ID# 201316
- Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 153896
- ISA Interdisciplinary Study Association GmbH /ID# 153907
- Hautarztpraxis Dr. Niesmann und Dr. Othlinghaus /ID# 154289
- Universitaetsklinikum Bonn /ID# 154094
- Klinikum Darmstadt /ID# 153893
- Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 153906
- Universitaetsmedizin Goettingen /ID# 154091
- Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 154089
- Klinische Forschung Hamburg GmbH /ID# 154290
- TFS Trial Form Support GmbH /ID# 153894
- Dermatologische Gemeinschaftspraxis Mahlow /ID# 153892
- Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz /ID# 154092
- Klinikum rechts der Isar - Technische Universitaet Muenchen /ID# 153915
- Klinische Forschung Schwerin GmbH /ID# 154291
- Hautarztpraxis Dr. med. Matthias Hoffmann /ID# 153917
- CentroDerm GmbH /ID# 153914
- Nagoya City University Hospital /ID# 153866
- Fukuoka University Hospital /ID# 153864
- Kurume University Hospital /ID# 156320
- Fukushima Medical University Hospital /ID# 153873
- Gifu University Hospital /ID# 169410
- JR Sapporo Hospital /ID# 201963
- Medical Cooperation Kojinkai Sapporo Skin Clinic /ID# 154083
- Hokkaido University Hospital /ID# 154285
- Kobe University Hospital /ID# 170706
- Iwate Medical University Hospital /ID# 170843
- Kagawa University Hospital /ID# 168656
- Japan Organization of Occupational Health and Society Kanto Rosai Hospital /ID# 169172
- National Hospital Organization Sagamihara National Hospital /ID# 153867
- Yokohama City University Hospital /ID# 168831
- University Hospital Kyoto Prefectural University of Medicine /ID# 169415
- Kyoto University Hospital /ID# 156318
- Mie University Hospital /ID# 156317
- Tohoku University Hospital /ID# 169006
- Shinshu University Hospital /ID# 170937
- Nagasaki University Hospital /ID# 170219
- Okayama University Hospital /ID# 200631
- Kansai Medical University Hospital /ID# 170884
- Osaka Metropolitan University Hospital /ID# 153869
- Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 156319
- Kindai University Hospital /ID# 153865
- Osaka University Hospital /ID# 156321
- Hamamatsu University Hospital /ID# 170132
- Jichi Medical University Hospital /ID# 154286
- Juntendo University Hospital /ID# 200292
- Nippon Medical School Hospital /ID# 154084
- Tokyo Teishin Hospital /ID# 165912
- St.Luke's International Hospital /ID# 153863
- Teikyo University Hospital /ID# 154287
- Nihon University Itabashi Hospital /ID# 154081
- The Jikei University Hospital /ID# 154080
- NTT Medical Center Tokyo /ID# 154082
- Tokyo Medical University Hospital /ID# 153874
- Japan Community Health care Organization Tokyo Yamate Medical Center /ID# 153868
- Yamaguchi University Hospital /ID# 156322
- Seoul National University Bundang Hospital /ID# 153491
- KonKuk University Medical Center /ID# 153483
- Korea Universtiy Guro Hospital /ID# 153490
- Pusan National University Hospital /ID# 153485
- Chonnam National University Hospital /ID# 153488
- Gachon University Gil Medical Center /ID# 153489
- Seoul National University Hospital /ID# 153484
- Samsung Medical Center /ID# 153487
- The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 153486
- Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 153882
- Derma Norte del Bajio S.C. /ID# 153880
- Centro de Dermatologia de Monterrey /ID# 153881
- Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu /ID# 153473
- Dermoklinika Medical Center /ID# 153470
- KO-MED Centra Kliniczne Lublin /ID# 153469
- Pratia MCM Krakow /ID# 153472
- High-Med Przychodnia Specjalistyczna /ID# 153468
- Klinika Ambroziak Sp. z o.o. /ID# 153467
- Osteo-Medic S.C. /ID# 156535
- Uniwersyteckie Centrum Kliniczne /ID# 153471
- Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 153884
- Solumed Centrum Medyczne /ID# 153466
- CCA Braga - Hospital de Braga /ID# 156323
- Centro Hospitalar Universitario de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 153462
- CHP, EPE- Hospital Geral de Sa /ID# 153464
- Centro Hospitalar Universitario de Sao Joao, EPE /ID# 153463
- Hospital Universitario Germans Trias i Pujol /ID# 153465
- Hospital Santa Creu i Sant Pau /ID# 154125
- Hospital Universitario Infanta Leonor /ID# 154121
- Hospital General Universitario de Valencia /ID# 154126
- Karolinska University Hospital Solna /ID# 154131
- Sahlgrenska University Hospital /ID# 154132
- Sodersjukhuset /ID# 154130
- Taipei Medical University Shuang Ho Hospital /ID# 154134
- National Cheng Kung University Hospital /ID# 154135
- National Taiwan University Hospital /ID# 154136
- Taiwan Adventist Hospital /ID# 154137
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Risankizumab
Arm Description
Participants will receive risankizumab administered by subcutaneous injection.
Outcomes
Primary Outcome Measures
Number of Participants With Adverse Events
An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. The investigator assessed the relationship of each event to the use of study drug as either probably related, possibly related, probably not related or not related. A serious adverse event (SAE) is an event that results in death, is life-threatening, requires or prolongs hospitalization, results in a congenital anomaly, persistent or significant disability/incapacity or is an important medical event that, based on medical judgment, may jeopardize the subject and may require medical or surgical intervention to prevent any of the outcomes listed above. Treatment-emergent events (TEAEs/TESAEs) are defined as any event that began or worsened in severity after the first dose of study drug.
Secondary Outcome Measures
Percentage of Participants Achieving an Static Physician Global Assessment (sPGA) Score of Clear
The sPGA is based on the physician's assessment of the average thickness, erythema, and scaling of all psoriatic lesions.
Percentage of Participants Achieving At Least 100% Reduction in PASI Score From Baseline (PASI 100)
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Percentage of Participants Achieving At Least 75% Reduction in PASI Score From Baseline (PASI 75)
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Percentage of Participants Achieving At Least 90% Reduction in Psoriasis Area and Severity Index (PASI) Score From Baseline (PASI 90)
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Percentage of Participants Achieving a Static Physician Global Assessment (sPGA) Score of Clear or Almost Clear
The sPGA is based on the physician's assessment of the average thickness, erythema, and scaling of all psoriatic lesions.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03047395
Brief Title
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
Acronym
LIMMITLESS
Official Title
A Multicenter, Open Label Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis (LIMMITLESS)
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 27, 2017 (Actual)
Primary Completion Date
November 30, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
AbbVie
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to investigate the long-term safety and efficacy of risankizumab in the treatment of moderate to severe chronic plaque psoriasis.
Detailed Description
This is a Phase 3, single-arm, multicenter open label extension (OLE) study designed to investigate the long-term safety and efficacy of 150 mg risankizumab in the treatment of moderate to severe chronic plaque psoriasis. Approximately 2200 participants who meet the entry criteria are planned to be enrolled in this study, rolling over from the preceding Phase 2/3 studies.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psoriasis
Keywords
ABBV-066, BI 655066
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2200 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Risankizumab
Arm Type
Experimental
Arm Description
Participants will receive risankizumab administered by subcutaneous injection.
Intervention Type
Biological
Intervention Name(s)
risankizumab
Other Intervention Name(s)
ABBV-066 BI 655066, Skyrizi
Intervention Description
Risankizumab 150 mg administered by subcutaneous injection every 12 weeks.
Primary Outcome Measure Information:
Title
Number of Participants With Adverse Events
Description
An adverse event (AE) is defined as any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. The investigator assessed the relationship of each event to the use of study drug as either probably related, possibly related, probably not related or not related. A serious adverse event (SAE) is an event that results in death, is life-threatening, requires or prolongs hospitalization, results in a congenital anomaly, persistent or significant disability/incapacity or is an important medical event that, based on medical judgment, may jeopardize the subject and may require medical or surgical intervention to prevent any of the outcomes listed above. Treatment-emergent events (TEAEs/TESAEs) are defined as any event that began or worsened in severity after the first dose of study drug.
Time Frame
From first dose of study drug until 20 weeks after last dose of study drug (up to 272 weeks)
Secondary Outcome Measure Information:
Title
Percentage of Participants Achieving an Static Physician Global Assessment (sPGA) Score of Clear
Description
The sPGA is based on the physician's assessment of the average thickness, erythema, and scaling of all psoriatic lesions.
Time Frame
Up to Week 252
Title
Percentage of Participants Achieving At Least 100% Reduction in PASI Score From Baseline (PASI 100)
Description
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Time Frame
Up to Week 252
Title
Percentage of Participants Achieving At Least 75% Reduction in PASI Score From Baseline (PASI 75)
Description
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Time Frame
Up to Week 252
Title
Percentage of Participants Achieving At Least 90% Reduction in Psoriasis Area and Severity Index (PASI) Score From Baseline (PASI 90)
Description
The PASI score is an established measure of clinical efficacy for psoriasis medications.
Time Frame
Up to Week 252
Title
Percentage of Participants Achieving a Static Physician Global Assessment (sPGA) Score of Clear or Almost Clear
Description
The sPGA is based on the physician's assessment of the average thickness, erythema, and scaling of all psoriatic lesions.
Time Frame
Up to Week 252
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participants with a history of moderate to severe chronic plaque psoriasis, who have completed one of the preceding studies.
Participants must be candidates for prolonged open label risankizumab treatment according to investigator judgment.
Females of childbearing potential must have a negative urine pregnancy test result at Baseline.
If female, participant must be either postmenopausal, OR permanently surgically sterile OR for women of childbearing potential practicing at least one protocol specified method of birth control, starting at Baseline through at least 20 weeks after the last dose of study drug.
- Participants must have signed and dated a written informed consent in accordance with Good Clinical Practice (GCP) and local legislation prior to admission into the study.
Exclusion Criteria:
Premature discontinuation for any reason in the preceding study.
Participants who have developed guttate, erythrodermic, pustular or drug-induced psoriasis as diagnosed by the investigator during the preceding study.
Use of any prohibited medication or any drug considered likely to interfere with the safe conduct of the study, as assessed by the investigator.
Evidence of a current or previous disease, medical condition (including chronic alcohol or drug abuse) other than psoriasis, surgical procedure (i.e., organ transplant), medical examination finding (including vital signs and ECG), or laboratory value outside the reference range that in the opinion of the investigator is clinically significant and would make the study participant unreliable to adhere to the protocol or to complete the study, compromise the safety of the subject, or compromise the quality of the data.
Previous enrollment in this study.
Female subject who is pregnant, breastfeeding or is considering becoming pregnant during the study or within 20 weeks after the last dose of study drug.
Time elapsed is > 8 weeks since the completion visit in the preceding study.
Participant is considered by the investigator for any reason, to be an unsuitable candidate for the study and not able to comply with the study protocol.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
ABBVIE INC.
Organizational Affiliation
AbbVie
Official's Role
Study Director
Facility Information:
Facility Name
Total Skin and Beauty Derm Ctr /ID# 154000
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35205
Country
United States
Facility Name
University of Alabama at Birmingham - Main /ID# 153983
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35233
Country
United States
Facility Name
NW Arkansas Clinical Trials Center /ID# 154014
City
Rogers
State/Province
Arkansas
ZIP/Postal Code
72758
Country
United States
Facility Name
Bakersfield Derma & Skin Cance /ID# 154008
City
Bakersfield
State/Province
California
ZIP/Postal Code
93309
Country
United States
Facility Name
California Dermatology and Research Institute /ID# 154007
City
Encinitas
State/Province
California
ZIP/Postal Code
92024
Country
United States
Facility Name
T. Joseph Raoof, MD, Inc. /ID# 154078
City
Encino
State/Province
California
ZIP/Postal Code
91436
Country
United States
Facility Name
Center for Dermatology Clinical Research /ID# 154009
City
Fremont
State/Province
California
ZIP/Postal Code
94538
Country
United States
Facility Name
Kaiser Permanente Los Angeles /ID# 154079
City
Los Angeles
State/Province
California
ZIP/Postal Code
90027
Country
United States
Facility Name
Dermatology Research Associates /ID# 153977
City
Los Angeles
State/Province
California
ZIP/Postal Code
90045
Country
United States
Facility Name
Wallace Medical Group /ID# 154025
City
Los Angeles
State/Province
California
ZIP/Postal Code
90056
Country
United States
Facility Name
Dermatology Specialists, Inc /ID# 153984
City
Oceanside
State/Province
California
ZIP/Postal Code
92056
Country
United States
Facility Name
Huntington Medical Foundation /ID# 154002
City
Pasadena
State/Province
California
ZIP/Postal Code
91105
Country
United States
Facility Name
Medderm Associates /ID# 154098
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Southern California Dermatology /ID# 154006
City
Santa Ana
State/Province
California
ZIP/Postal Code
92701
Country
United States
Facility Name
UNISON Center for Clinical Tri /ID# 153979
City
Sherman Oaks
State/Province
California
ZIP/Postal Code
91403
Country
United States
Facility Name
New England Research Associates, LLC /ID# 154004
City
Bridgeport
State/Province
Connecticut
ZIP/Postal Code
06606-1827
Country
United States
Facility Name
UConn Health /ID# 154128
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030
Country
United States
Facility Name
Florida Academic Centers Research /ID# 154045
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Facility Name
Leavitt Medical Associates of Florida /ID# 154046
City
Ormond Beach
State/Province
Florida
ZIP/Postal Code
32174
Country
United States
Facility Name
Progressive Medical Research /ID# 154027
City
Port Orange
State/Province
Florida
ZIP/Postal Code
32127
Country
United States
Facility Name
Hamilton Research, LLC /ID# 153980
City
Alpharetta
State/Province
Georgia
ZIP/Postal Code
30022
Country
United States
Facility Name
Advanced Medical Research, PC /ID# 153999
City
Sandy Springs
State/Province
Georgia
ZIP/Postal Code
30328-6141
Country
United States
Facility Name
Northwestern University Feinberg School of Medicine /ID# 153974
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611-2927
Country
United States
Facility Name
Rush University Medical Center /ID# 154099
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60612
Country
United States
Facility Name
Arlington Dermatology /ID# 153975
City
Rolling Meadows
State/Province
Illinois
ZIP/Postal Code
60008
Country
United States
Facility Name
Northshore University Health System Dermatology Clinical Trials Unit /ID# 154011
City
Skokie
State/Province
Illinois
ZIP/Postal Code
60077
Country
United States
Facility Name
Dundee Dermatology /ID# 154110
City
West Dundee
State/Province
Illinois
ZIP/Postal Code
60118
Country
United States
Facility Name
Dawes Fretzin, LLC /ID# 154146
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46256
Country
United States
Facility Name
The Dermatology Center PSC - New Albany /ID# 154075
City
New Albany
State/Province
Indiana
ZIP/Postal Code
47150
Country
United States
Facility Name
The Indiana Clinical Trials Center /ID# 153976
City
Plainfield
State/Province
Indiana
ZIP/Postal Code
46168
Country
United States
Facility Name
The South Bend Clinic Center /ID# 154147
City
South Bend
State/Province
Indiana
ZIP/Postal Code
46617
Country
United States
Facility Name
Epiphany Dermatology of Kansas LLC /ID# 153993
City
Overland Park
State/Province
Kansas
ZIP/Postal Code
66210
Country
United States
Facility Name
Skin Sciences, PLLC /ID# 153991
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40217
Country
United States
Facility Name
DS Research /ID# 154028
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40241
Country
United States
Facility Name
Massachusetts General Hospital /ID# 153990
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Facility Name
ActivMed Practices and Research, LLC. /ID# 154044
City
Methuen
State/Province
Massachusetts
ZIP/Postal Code
01844
Country
United States
Facility Name
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 154111
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
Facility Name
Great Lakes Research Group, Inc. /ID# 153998
City
Bay City
State/Province
Michigan
ZIP/Postal Code
48602
Country
United States
Facility Name
Michigan Center for Skin Care Research /ID# 153986
City
Clinton Township
State/Province
Michigan
ZIP/Postal Code
48038
Country
United States
Facility Name
Somerset Skin Centre /ID# 154097
City
Troy
State/Province
Michigan
ZIP/Postal Code
48084
Country
United States
Facility Name
Minnesota Clinical Study Center /ID# 154015
City
New Brighton
State/Province
Minnesota
ZIP/Postal Code
55112
Country
United States
Facility Name
Central Dermatology, PC /ID# 154013
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63117
Country
United States
Facility Name
Skin Specialists, PC /ID# 154024
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68144
Country
United States
Facility Name
Dartmouth-Hitchcock Medical Center /ID# 154095
City
Lebanon
State/Province
New Hampshire
ZIP/Postal Code
03756
Country
United States
Facility Name
Psoriasis Treatment Center of Central New Jersey /ID# 154001
City
East Windsor
State/Province
New Jersey
ZIP/Postal Code
08520
Country
United States
Facility Name
Schweiger Dermatology Group /ID# 202489
City
Verona
State/Province
New Jersey
ZIP/Postal Code
07044
Country
United States
Facility Name
Forest Hills Dermatology Group /ID# 154113
City
Kew Gardens
State/Province
New York
ZIP/Postal Code
11415
Country
United States
Facility Name
Icahn School of Medicine at Mount Sinai /ID# 154129
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
Facility Name
The Rockefeller University /ID# 153994
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
Facility Name
DermResearchCenter of New York, Inc. /ID# 154012
City
Stony Brook
State/Province
New York
ZIP/Postal Code
11790
Country
United States
Facility Name
Buffalo Medical Group /ID# 154148
City
Williamsville
State/Province
New York
ZIP/Postal Code
14221
Country
United States
Facility Name
Darst Dermatology /ID# 154076
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
Facility Name
Dermatology Consulting Service /ID# 154010
City
High Point
State/Province
North Carolina
ZIP/Postal Code
27262
Country
United States
Facility Name
Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 202490
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27612
Country
United States
Facility Name
Wilmington Dermatology Center /ID# 154109
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28403
Country
United States
Facility Name
Synexus Research Cincinnati /ID# 153997
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45236
Country
United States
Facility Name
Oregon Dermatology and Research Center /ID# 153982
City
Portland
State/Province
Oregon
ZIP/Postal Code
97210
Country
United States
Facility Name
Oregon Medical Res Center PC /ID# 154003
City
Portland
State/Province
Oregon
ZIP/Postal Code
97223
Country
United States
Facility Name
Altoona Ctr Clinical Res /ID# 153981
City
Duncansville
State/Province
Pennsylvania
ZIP/Postal Code
16635
Country
United States
Facility Name
Paddington Testing Co., Inc. /ID# 154022
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19103
Country
United States
Facility Name
University of Pittsburgh MC /ID# 153995
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15260
Country
United States
Facility Name
Clinical Partners, LLC /ID# 154096
City
Johnston
State/Province
Rhode Island
ZIP/Postal Code
02919
Country
United States
Facility Name
Coastal Clinical Research Center of the Carolinas /ID# 154112
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29414
Country
United States
Facility Name
Synexus Clinical Research US, Inc. /ID# 154127
City
Greer
State/Province
South Carolina
ZIP/Postal Code
29651-1123
Country
United States
Facility Name
Coastal Carolina Research Center /ID# 153992
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29405
Country
United States
Facility Name
Health Concepts /ID# 153996
City
Rapid City
State/Province
South Dakota
ZIP/Postal Code
57702
Country
United States
Facility Name
Austin Dermatology Associates /ID# 154042
City
Austin
State/Province
Texas
ZIP/Postal Code
78705
Country
United States
Facility Name
Bellaire Dermatology Associates /ID# 153987
City
Bellaire
State/Province
Texas
ZIP/Postal Code
77401
Country
United States
Facility Name
Modern Research Associates, PLLC /ID# 154043
City
Dallas
State/Province
Texas
ZIP/Postal Code
75231
Country
United States
Facility Name
Menter Dermatology Res Inst /ID# 153985
City
Dallas
State/Province
Texas
ZIP/Postal Code
75246
Country
United States
Facility Name
Center for Clinical Studies - Houston (Binz) /ID# 154005
City
Houston
State/Province
Texas
ZIP/Postal Code
77004-8097
Country
United States
Facility Name
Suzanne Bruce and Associates-Houston /ID# 154026
City
Houston
State/Province
Texas
ZIP/Postal Code
77056
Country
United States
Facility Name
Derm Clin Res Ctr San Antonio /ID# 153978
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Progressive Clinical Research /ID# 154149
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Dermatology San Antonio /ID# 154077
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78249
Country
United States
Facility Name
Center for Clinical Studies - Webster TX /ID# 154150
City
Webster
State/Province
Texas
ZIP/Postal Code
77598
Country
United States
Facility Name
Virginia Clinical Research, Inc. /ID# 154016
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23507
Country
United States
Facility Name
Dermatology Associates of Seattle /ID# 153988
City
Seattle
State/Province
Washington
ZIP/Postal Code
98101
Country
United States
Facility Name
Premier Clinical Research /ID# 154284
City
Spokane
State/Province
Washington
ZIP/Postal Code
99202
Country
United States
Facility Name
Paratus Clinical Research Woden /ID# 154307
City
Phillip
State/Province
Australian Capital Territory
ZIP/Postal Code
2606
Country
Australia
Facility Name
St George Dermatology & Skin Cancer Centre /ID# 154308
City
Kogarah
State/Province
New South Wales
ZIP/Postal Code
2217
Country
Australia
Facility Name
Specialist Connect Pty Ltd /ID# 154311
City
Woolloongabba
State/Province
Queensland
ZIP/Postal Code
4102
Country
Australia
Facility Name
North Eastern Health Specialists /ID# 154309
City
Campbelltown
State/Province
South Australia
ZIP/Postal Code
5074
Country
Australia
Facility Name
Skin Health Institute Inc /ID# 154305
City
Carlton
State/Province
Victoria
ZIP/Postal Code
3053
Country
Australia
Facility Name
Sinclair Dermatology /ID# 154310
City
East Melbourne
State/Province
Victoria
ZIP/Postal Code
3002
Country
Australia
Facility Name
Fremantle Dermatology /ID# 154306
City
Fremantle
State/Province
Western Australia
ZIP/Postal Code
6160
Country
Australia
Facility Name
Landeskrankenhaus Feldkirch /ID# 154303
City
Feldkirch
State/Province
Vorarlberg
ZIP/Postal Code
6800
Country
Austria
Facility Name
Klinik Landstrasse /ID# 154300
City
Vienna
State/Province
Wien
ZIP/Postal Code
1030
Country
Austria
Facility Name
Medizinische Universitaet Wien /ID# 154302
City
Vienna
State/Province
Wien
ZIP/Postal Code
1090
Country
Austria
Facility Name
Cliniques Universitaires de Bruxelles Hopital Erasme /ID# 154293
City
Brussels
State/Province
Bruxelles-Capitale
ZIP/Postal Code
1070
Country
Belgium
Facility Name
UZ Brussel /ID# 154295
City
Jette
State/Province
Bruxelles-Capitale
ZIP/Postal Code
1090
Country
Belgium
Facility Name
UCL Saint-Luc /ID# 154294
City
Woluwe-Saint-Lambert
State/Province
Bruxelles-Capitale
ZIP/Postal Code
1200
Country
Belgium
Facility Name
CHU de Liege Sart Tilman /ID# 154297
City
Liège
State/Province
Liege
ZIP/Postal Code
4000
Country
Belgium
Facility Name
UZ Gent /ID# 154296
City
Gent
State/Province
Oost-Vlaanderen
ZIP/Postal Code
9000
Country
Belgium
Facility Name
IMTR - Grand Hopital de Charleroi /ID# 154298
City
Loverval
ZIP/Postal Code
6280
Country
Belgium
Facility Name
Kirk Barber Research, CA /ID# 153840
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2G 1B1
Country
Canada
Facility Name
Dermatology Research Institute Inc. /ID# 153850
City
Calgary
State/Province
Alberta
ZIP/Postal Code
T2J 7E1
Country
Canada
Facility Name
Stratica Medical /ID# 153848
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T5K 1X3
Country
Canada
Facility Name
Dr. Chih-ho Hong Medical Inc. /ID# 153842
City
Surrey
State/Province
British Columbia
ZIP/Postal Code
V3R 6A7
Country
Canada
Facility Name
Enverus Medical Research /ID# 153851
City
Surrey
State/Province
British Columbia
ZIP/Postal Code
V3V 0C6
Country
Canada
Facility Name
Karma Clinical Trials /ID# 153876
City
St. John's
State/Province
Newfoundland and Labrador
ZIP/Postal Code
A1A 4Y3
Country
Canada
Facility Name
Eastern Canada Cutaneous Resea /ID# 153870
City
Halifax
State/Province
Nova Scotia
ZIP/Postal Code
B3H 1Z2
Country
Canada
Facility Name
CCA Medical Research /ID# 153859
City
Ajax
State/Province
Ontario
ZIP/Postal Code
L1S 7K8
Country
Canada
Facility Name
Kingsway Clinical Research /ID# 154292
City
Etobicoke
State/Province
Ontario
ZIP/Postal Code
M8X 1Y9
Country
Canada
Facility Name
Dermatrials Research /ID# 153847
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 1Y2
Country
Canada
Facility Name
The Guenther Dermatology Research Centre /ID# 153841
City
London
State/Province
Ontario
ZIP/Postal Code
N6A 3H7
Country
Canada
Facility Name
Lynderm Research Inc. /ID# 153861
City
Markham
State/Province
Ontario
ZIP/Postal Code
L3P 1X2
Country
Canada
Facility Name
DermEdge Research Inc. /ID# 153843
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L4Y 4C5
Country
Canada
Facility Name
North Bay Dermatology Centre /ID# 153845
City
North Bay
State/Province
Ontario
ZIP/Postal Code
P1B 3Z7
Country
Canada
Facility Name
The Centre for Clinical Trials /ID# 153871
City
Oakville
State/Province
Ontario
ZIP/Postal Code
L6J 7W5
Country
Canada
Facility Name
Dermatology Ottawa Research Centre /ID# 153862
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K2C 3N2
Country
Canada
Facility Name
SKIN Centre for Dermatology /ID# 153853
City
Peterborough
State/Province
Ontario
ZIP/Postal Code
K9J 5K2
Country
Canada
Facility Name
The Center For Dermatology /ID# 153844
City
Richmond Hill
State/Province
Ontario
ZIP/Postal Code
L4B 1A5
Country
Canada
Facility Name
York Dermatology Clinic and Research Centre /ID# 153860
City
Richmond Hill
State/Province
Ontario
ZIP/Postal Code
L4C 9M7
Country
Canada
Facility Name
Toronto Research Centre /ID# 153852
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M3H 5Y8
Country
Canada
Facility Name
Research Toronto /ID# 153854
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4W 2N4
Country
Canada
Facility Name
K. Papp Clinical Research /ID# 153855
City
Waterloo
State/Province
Ontario
ZIP/Postal Code
N2J 1C4
Country
Canada
Facility Name
XLR8 Medical Research /ID# 153858
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8W 1E6
Country
Canada
Facility Name
Windsor Clinical Research, Inc /ID# 153877
City
Windsor
State/Province
Ontario
ZIP/Postal Code
N8W 5L7
Country
Canada
Facility Name
Innovaderm Research Inc. /ID# 153846
City
Montréal
State/Province
Quebec
ZIP/Postal Code
H2X 2V1
Country
Canada
Facility Name
Centre de Recherche dermatologique du Quebec Metropolitain /ID# 153856
City
Québec
State/Province
Quebec
ZIP/Postal Code
G1V 4X7
Country
Canada
Facility Name
DERMAMEDICA, s.r.o. /ID# 153890
City
Cerveny Kostelec
ZIP/Postal Code
549 41
Country
Czechia
Facility Name
Medical research s.r.o. /ID# 153898
City
Ostrava
ZIP/Postal Code
735 14
Country
Czechia
Facility Name
CLINTRIAL s.r.o. /ID# 153889
City
Prague 10
ZIP/Postal Code
100 00
Country
Czechia
Facility Name
CCR Czech a.s /ID# 153887
City
Prague 4
ZIP/Postal Code
140 00
Country
Czechia
Facility Name
MUDr. Blanka Havlickova - dermatovenerologie /ID# 153888
City
Praha
ZIP/Postal Code
110 00
Country
Czechia
Facility Name
CCR Prague s.r.o. /ID# 153897
City
Praha
ZIP/Postal Code
130 00
Country
Czechia
Facility Name
Terveystalo Tampere /ID# 154118
City
Tampere
ZIP/Postal Code
33100
Country
Finland
Facility Name
Mehilainen Turku /ID# 154120
City
Turku
ZIP/Postal Code
20100
Country
Finland
Facility Name
Chu de Nice-Hopital L'Archet Ii /Id# 153948
City
Nice
State/Province
Alpes-Maritimes
ZIP/Postal Code
06200
Country
France
Facility Name
Hôpital Charles-Nicolle /ID# 205842
City
Rouen
ZIP/Postal Code
76000
Country
France
Facility Name
CHU Toulouse - Hopital Larrey /ID# 153951
City
Toulouse
ZIP/Postal Code
31400
Country
France
Facility Name
Universitaetsklinik Heidelberg /ID# 153910
City
Heidelberg
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
69120
Country
Germany
Facility Name
Universitaetsklinikum Tuebingen /ID# 153912
City
Tubingen
State/Province
Baden-Wuerttemberg
ZIP/Postal Code
72076
Country
Germany
Facility Name
Universitaetsklinikum Erlangen /ID# 154093
City
Erlangen
State/Province
Bayern
ZIP/Postal Code
91054
Country
Germany
Facility Name
Universitaetsklinikum Frankfurt /ID# 153891
City
Frankfurt am Main
State/Province
Hessen
ZIP/Postal Code
60590
Country
Germany
Facility Name
Universitaetsklinikum Muenster /ID# 153895
City
Munster
State/Province
Niedersachsen
ZIP/Postal Code
48149
Country
Germany
Facility Name
CMS3 Company for Medical Study /ID# 201318
City
Selters
State/Province
Rheinland-Pfalz
ZIP/Postal Code
56242
Country
Germany
Facility Name
Universitaetsklinikum Leipzig /ID# 153909
City
Leipzig
State/Province
Sachsen
ZIP/Postal Code
04103
Country
Germany
Facility Name
Universitaetsklinikum Schleswig-Holstein Campus Kiel /ID# 153916
City
Kiel
State/Province
Schleswig-Holstein
ZIP/Postal Code
24105
Country
Germany
Facility Name
DermaKiel Allergie und Haut Centrum /ID# 201316
City
Kiel
State/Province
Schleswig-Holstein
ZIP/Postal Code
24148
Country
Germany
Facility Name
Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 153896
City
Berlin
ZIP/Postal Code
10117
Country
Germany
Facility Name
ISA Interdisciplinary Study Association GmbH /ID# 153907
City
Berlin
ZIP/Postal Code
10789
Country
Germany
Facility Name
Hautarztpraxis Dr. Niesmann und Dr. Othlinghaus /ID# 154289
City
Bochum
ZIP/Postal Code
44793
Country
Germany
Facility Name
Universitaetsklinikum Bonn /ID# 154094
City
Bonn
ZIP/Postal Code
53127
Country
Germany
Facility Name
Klinikum Darmstadt /ID# 153893
City
Darmstadt
ZIP/Postal Code
64283
Country
Germany
Facility Name
Universitaetsklinikum Carl Gustav Carus an der TU Dresden /ID# 153906
City
Dresden
ZIP/Postal Code
01307
Country
Germany
Facility Name
Universitaetsmedizin Goettingen /ID# 154091
City
Goettingen
ZIP/Postal Code
37075
Country
Germany
Facility Name
Universitaetsklinikum Hamburg-Eppendorf (UKE) /ID# 154089
City
Hamburg
ZIP/Postal Code
20246
Country
Germany
Facility Name
Klinische Forschung Hamburg GmbH /ID# 154290
City
Hamburg
ZIP/Postal Code
20253
Country
Germany
Facility Name
TFS Trial Form Support GmbH /ID# 153894
City
Hamburg
ZIP/Postal Code
20537
Country
Germany
Facility Name
Dermatologische Gemeinschaftspraxis Mahlow /ID# 153892
City
Mahlow
ZIP/Postal Code
15831
Country
Germany
Facility Name
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz /ID# 154092
City
Mainz
ZIP/Postal Code
55131
Country
Germany
Facility Name
Klinikum rechts der Isar - Technische Universitaet Muenchen /ID# 153915
City
Munich
ZIP/Postal Code
81675
Country
Germany
Facility Name
Klinische Forschung Schwerin GmbH /ID# 154291
City
Schwerin
ZIP/Postal Code
19055
Country
Germany
Facility Name
Hautarztpraxis Dr. med. Matthias Hoffmann /ID# 153917
City
Witten
ZIP/Postal Code
58453
Country
Germany
Facility Name
CentroDerm GmbH /ID# 153914
City
Wuppertal
ZIP/Postal Code
42287
Country
Germany
Facility Name
Nagoya City University Hospital /ID# 153866
City
Nagoya shi
State/Province
Aichi
ZIP/Postal Code
467-8602
Country
Japan
Facility Name
Fukuoka University Hospital /ID# 153864
City
Fukuoka-shi
State/Province
Fukuoka
ZIP/Postal Code
814-0180
Country
Japan
Facility Name
Kurume University Hospital /ID# 156320
City
Kurume-shi
State/Province
Fukuoka
ZIP/Postal Code
830-0011
Country
Japan
Facility Name
Fukushima Medical University Hospital /ID# 153873
City
Fukushima-shi
State/Province
Fukushima
ZIP/Postal Code
960-1295
Country
Japan
Facility Name
Gifu University Hospital /ID# 169410
City
Gifu-shi
State/Province
Gifu
ZIP/Postal Code
501-1194
Country
Japan
Facility Name
JR Sapporo Hospital /ID# 201963
City
Sapporo-shi
State/Province
Hokkaido
ZIP/Postal Code
060-0033
Country
Japan
Facility Name
Medical Cooperation Kojinkai Sapporo Skin Clinic /ID# 154083
City
Sapporo-shi
State/Province
Hokkaido
ZIP/Postal Code
060-0063
Country
Japan
Facility Name
Hokkaido University Hospital /ID# 154285
City
Sapporo-shi
State/Province
Hokkaido
ZIP/Postal Code
060-8648
Country
Japan
Facility Name
Kobe University Hospital /ID# 170706
City
Kobe-shi
State/Province
Hyogo
ZIP/Postal Code
650-0017
Country
Japan
Facility Name
Iwate Medical University Hospital /ID# 170843
City
Shiwa-gun
State/Province
Iwate
ZIP/Postal Code
028-3695
Country
Japan
Facility Name
Kagawa University Hospital /ID# 168656
City
Kita-gun
State/Province
Kagawa
ZIP/Postal Code
761-0793
Country
Japan
Facility Name
Japan Organization of Occupational Health and Society Kanto Rosai Hospital /ID# 169172
City
Kawasaki-shi
State/Province
Kanagawa
ZIP/Postal Code
211-8510
Country
Japan
Facility Name
National Hospital Organization Sagamihara National Hospital /ID# 153867
City
Sagamihara-shi
State/Province
Kanagawa
ZIP/Postal Code
252-0392
Country
Japan
Facility Name
Yokohama City University Hospital /ID# 168831
City
Yokohama-shi
State/Province
Kanagawa
ZIP/Postal Code
236-0004
Country
Japan
Facility Name
University Hospital Kyoto Prefectural University of Medicine /ID# 169415
City
Kyoto-shi
State/Province
Kyoto
ZIP/Postal Code
602-8566
Country
Japan
Facility Name
Kyoto University Hospital /ID# 156318
City
Kyoto-shi
State/Province
Kyoto
ZIP/Postal Code
606-8507
Country
Japan
Facility Name
Mie University Hospital /ID# 156317
City
Tsu-shi
State/Province
Mie
ZIP/Postal Code
514-8507
Country
Japan
Facility Name
Tohoku University Hospital /ID# 169006
City
Sendai-shi
State/Province
Miyagi
ZIP/Postal Code
9808574
Country
Japan
Facility Name
Shinshu University Hospital /ID# 170937
City
Matsumoto-shi
State/Province
Nagano
ZIP/Postal Code
390-8621
Country
Japan
Facility Name
Nagasaki University Hospital /ID# 170219
City
Nagasaki-shi
State/Province
Nagasaki
ZIP/Postal Code
852-8501
Country
Japan
Facility Name
Okayama University Hospital /ID# 200631
City
Okayama-shi
State/Province
Okayama
ZIP/Postal Code
700-8558
Country
Japan
Facility Name
Kansai Medical University Hospital /ID# 170884
City
Hirakata-shi
State/Province
Osaka
ZIP/Postal Code
573-1191
Country
Japan
Facility Name
Osaka Metropolitan University Hospital /ID# 153869
City
Osaka-shi
State/Province
Osaka
ZIP/Postal Code
545-8586
Country
Japan
Facility Name
Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 156319
City
Osaka-shi
State/Province
Osaka
ZIP/Postal Code
550-0006
Country
Japan
Facility Name
Kindai University Hospital /ID# 153865
City
Osakasayama-shi
State/Province
Osaka
ZIP/Postal Code
589-8511
Country
Japan
Facility Name
Osaka University Hospital /ID# 156321
City
Suita-shi
State/Province
Osaka
ZIP/Postal Code
565-0871
Country
Japan
Facility Name
Hamamatsu University Hospital /ID# 170132
City
Hamamatsu-shi
State/Province
Shizuoka
ZIP/Postal Code
431-3192
Country
Japan
Facility Name
Jichi Medical University Hospital /ID# 154286
City
Shimotsuke-shi
State/Province
Tochigi
ZIP/Postal Code
329-0498
Country
Japan
Facility Name
Juntendo University Hospital /ID# 200292
City
Bunkyo-ku
State/Province
Tokyo
ZIP/Postal Code
113-8431
Country
Japan
Facility Name
Nippon Medical School Hospital /ID# 154084
City
Bunkyo-ku
State/Province
Tokyo
ZIP/Postal Code
113-8602
Country
Japan
Facility Name
Tokyo Teishin Hospital /ID# 165912
City
Chiyoda-ku
State/Province
Tokyo
ZIP/Postal Code
102-8798
Country
Japan
Facility Name
St.Luke's International Hospital /ID# 153863
City
Chuo-ku
State/Province
Tokyo
ZIP/Postal Code
104-8560
Country
Japan
Facility Name
Teikyo University Hospital /ID# 154287
City
Itabashi-ku
State/Province
Tokyo
ZIP/Postal Code
173-8606
Country
Japan
Facility Name
Nihon University Itabashi Hospital /ID# 154081
City
Itabashi-ku
State/Province
Tokyo
ZIP/Postal Code
173-8610
Country
Japan
Facility Name
The Jikei University Hospital /ID# 154080
City
Minato-ku
State/Province
Tokyo
ZIP/Postal Code
105-8471
Country
Japan
Facility Name
NTT Medical Center Tokyo /ID# 154082
City
Shinagawa-ku
State/Province
Tokyo
ZIP/Postal Code
141-8625
Country
Japan
Facility Name
Tokyo Medical University Hospital /ID# 153874
City
Shinjuku-ku
State/Province
Tokyo
ZIP/Postal Code
160-0023
Country
Japan
Facility Name
Japan Community Health care Organization Tokyo Yamate Medical Center /ID# 153868
City
Shinjuku-ku
State/Province
Tokyo
ZIP/Postal Code
169-0073
Country
Japan
Facility Name
Yamaguchi University Hospital /ID# 156322
City
Ube-shi
State/Province
Yamaguchi
ZIP/Postal Code
755-8505
Country
Japan
Facility Name
Seoul National University Bundang Hospital /ID# 153491
City
Seongnam
State/Province
Gyeonggido
ZIP/Postal Code
13620
Country
Korea, Republic of
Facility Name
KonKuk University Medical Center /ID# 153483
City
Seoul
State/Province
Seoul Teugbyeolsi
ZIP/Postal Code
05030
Country
Korea, Republic of
Facility Name
Korea Universtiy Guro Hospital /ID# 153490
City
Seoul
State/Province
Seoul Teugbyeolsi
ZIP/Postal Code
08308
Country
Korea, Republic of
Facility Name
Pusan National University Hospital /ID# 153485
City
Busan
ZIP/Postal Code
49241
Country
Korea, Republic of
Facility Name
Chonnam National University Hospital /ID# 153488
City
Gwangju
ZIP/Postal Code
61469
Country
Korea, Republic of
Facility Name
Gachon University Gil Medical Center /ID# 153489
City
Incheon
ZIP/Postal Code
21565
Country
Korea, Republic of
Facility Name
Seoul National University Hospital /ID# 153484
City
Seoul
ZIP/Postal Code
03080
Country
Korea, Republic of
Facility Name
Samsung Medical Center /ID# 153487
City
Seoul
ZIP/Postal Code
06351
Country
Korea, Republic of
Facility Name
The Catholic University of Korea, Seoul St. Mary's Hospital /ID# 153486
City
Seoul
ZIP/Postal Code
06591
Country
Korea, Republic of
Facility Name
Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 153882
City
Monterrey
State/Province
Nuevo Leon
ZIP/Postal Code
64460
Country
Mexico
Facility Name
Derma Norte del Bajio S.C. /ID# 153880
City
Aguascalientes
ZIP/Postal Code
20130
Country
Mexico
Facility Name
Centro de Dermatologia de Monterrey /ID# 153881
City
Monterrey
ZIP/Postal Code
64640
Country
Mexico
Facility Name
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu /ID# 153473
City
Wroclaw
State/Province
Dolnoslaskie
ZIP/Postal Code
50-556
Country
Poland
Facility Name
Dermoklinika Medical Center /ID# 153470
City
Lodz
State/Province
Lodzkie
ZIP/Postal Code
90-436
Country
Poland
Facility Name
KO-MED Centra Kliniczne Lublin /ID# 153469
City
Lublin
State/Province
Lubelskie
ZIP/Postal Code
20-362
Country
Poland
Facility Name
Pratia MCM Krakow /ID# 153472
City
Krakow
State/Province
Malopolskie
ZIP/Postal Code
30-727
Country
Poland
Facility Name
High-Med Przychodnia Specjalistyczna /ID# 153468
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
01-817
Country
Poland
Facility Name
Klinika Ambroziak Sp. z o.o. /ID# 153467
City
Warszawa
State/Province
Mazowieckie
ZIP/Postal Code
02-953
Country
Poland
Facility Name
Osteo-Medic S.C. /ID# 156535
City
Bialystok
State/Province
Podlaskie
ZIP/Postal Code
15-351
Country
Poland
Facility Name
Uniwersyteckie Centrum Kliniczne /ID# 153471
City
Gdansk
State/Province
Pomorskie
ZIP/Postal Code
80-214
Country
Poland
Facility Name
Centrum Badan Klinicznych PI-House sp. z o.o. /ID# 153884
City
Gdansk
State/Province
Pomorskie
ZIP/Postal Code
80-546
Country
Poland
Facility Name
Solumed Centrum Medyczne /ID# 153466
City
Poznan
State/Province
Wielkopolskie
ZIP/Postal Code
60-529
Country
Poland
Facility Name
CCA Braga - Hospital de Braga /ID# 156323
City
Braga
ZIP/Postal Code
4710-243
Country
Portugal
Facility Name
Centro Hospitalar Universitario de Lisboa Norte, EPE - Hospital de Santa Maria /ID# 153462
City
Lisboa
ZIP/Postal Code
1649-035
Country
Portugal
Facility Name
CHP, EPE- Hospital Geral de Sa /ID# 153464
City
Porto
ZIP/Postal Code
4050
Country
Portugal
Facility Name
Centro Hospitalar Universitario de Sao Joao, EPE /ID# 153463
City
Porto
ZIP/Postal Code
4200-319
Country
Portugal
Facility Name
Hospital Universitario Germans Trias i Pujol /ID# 153465
City
Badalona
State/Province
Barcelona
ZIP/Postal Code
08916
Country
Spain
Facility Name
Hospital Santa Creu i Sant Pau /ID# 154125
City
Barcelona
ZIP/Postal Code
08041
Country
Spain
Facility Name
Hospital Universitario Infanta Leonor /ID# 154121
City
Madrid
ZIP/Postal Code
28031
Country
Spain
Facility Name
Hospital General Universitario de Valencia /ID# 154126
City
Valencia
ZIP/Postal Code
46014
Country
Spain
Facility Name
Karolinska University Hospital Solna /ID# 154131
City
Solna
State/Province
Stockholms Lan
ZIP/Postal Code
171 64
Country
Sweden
Facility Name
Sahlgrenska University Hospital /ID# 154132
City
Gothenburg
State/Province
Vastra Gotalands Lan
ZIP/Postal Code
413 46
Country
Sweden
Facility Name
Sodersjukhuset /ID# 154130
City
Stockholm
ZIP/Postal Code
118 83
Country
Sweden
Facility Name
Taipei Medical University Shuang Ho Hospital /ID# 154134
City
New Taipei City
ZIP/Postal Code
23561
Country
Taiwan
Facility Name
National Cheng Kung University Hospital /ID# 154135
City
Tainan
ZIP/Postal Code
704
Country
Taiwan
Facility Name
National Taiwan University Hospital /ID# 154136
City
Taipei City
ZIP/Postal Code
100
Country
Taiwan
Facility Name
Taiwan Adventist Hospital /ID# 154137
City
Taipei
ZIP/Postal Code
105
Country
Taiwan
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
AbbVie is committed to responsible data sharing regarding the clinical trials we sponsor. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information (e.g., protocols, analyses plans, clinical study reports), as long as the trials are not part of an ongoing or planned regulatory submission. This includes requests for clinical trial data for unlicensed products and indications.
IPD Sharing Time Frame
For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/
IPD Sharing Access Criteria
Access to this clinical trial data can be requested by any qualified researchers who engage in rigorous independent scientific research, and will be provided following review and approval of a research proposal and statistical analysis plan and execution of a data sharing statement. Data requests can be submitted at any time after approval in the US and/or EU and a primary manuscript is accepted for publication. For more information on the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/
IPD Sharing URL
https://vivli.org/ourmember/abbvie/
Citations:
PubMed Identifier
34157132
Citation
Papp KA, Lebwohl MG, Puig L, Ohtsuki M, Beissert S, Zeng J, Rubant S, Sinvhal R, Zhao Y, Soliman AM, Alperovich G, Leonardi C. Long-term efficacy and safety of risankizumab for the treatment of moderate-to-severe plaque psoriasis: interim analysis of the LIMMitless open-label extension trial beyond 3 years of follow-up. Br J Dermatol. 2021 Dec;185(6):1135-1145. doi: 10.1111/bjd.20595. Epub 2021 Sep 21.
Results Reference
derived
Learn more about this trial
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
We'll reach out to this number within 24 hrs